Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>On September 12, 2025, Cocrystal Pharma, Inc. (COCP) announced a presentation on CDI-988 at the 9th International Calicivirus Conference.</li><li>The presentation emphasized CDI-988's favorable safety profile along with its high exposure in the small intestine.</li><li>In addition, results from the Phase 1 trial were shared that included the fact no serious adverse events were reported.</li></ul>

On September 12, 2025, Cocrystal Pharma, Inc. (COCP) announced a presentation on CDI-988 at the 9th International Calicivirus Conference.The presentation emphasized CDI-988's favorable safety profile along with its high exposure in the small intestine.In addition, results from the Phase 1 trial were shared that included the fact no serious adverse events were reported.

COCP: CDI-988 Showcased at Calicivirus Conference  Direct Offering Raises Up to 13 Million 